Chemoinformaics analysis of 8-[(2S)-2,3-DIHYDROXY-3-METHYLBUTYL]-7-METHOXYCHROMEN-2-ONE
| Molecular Weight | 278.304 | nRot | 4 |
| Heavy Atom Molecular Weight | 260.16 | nRig | 12 |
| Exact Molecular Weight | 278.115 | nRing | 2 |
| Solubility: LogS | -2.275 | nHRing | 1 |
| Solubility: LogP | 1.426 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 38 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 1 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 10 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 11 |
| nHA | 5 | APOL | 41.0623 |
| nHD | 2 | BPOL | 22.3977 |
| QED | 0.828 |
| Synth | 3.012 |
| Natural Product Likeliness | 1.65 |
| NR-PPAR-gamma | 0.026 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.077 |
| HIA | 0.029 |
| CACO-2 | -4.782 |
| MDCK | 0.0000346 |
| BBB | 0.351 |
| PPB | 0.75671 |
| VDSS | 0.919 |
| FU | 0.233585 |
| CYP1A2-inh | 0.583 |
| CYP1A2-sub | 0.845 |
| CYP2c19-inh | 0.064 |
| CYP2c19-sub | 0.49 |
| CYP2c9-inh | 0.045 |
| CYP2c9-sub | 0.786 |
| CYP2d6-inh | 0.132 |
| CYP2d6-sub | 0.684 |
| CYP3a4-inh | 0.021 |
| CYP3a4-sub | 0.258 |
| CL | 9.996 |
| T12 | 0.736 |
| hERG | 0.012 |
| Ames | 0.15 |
| ROA | 0.283 |
| SkinSen | 0.133 |
| Carcinogencity | 0.826 |
| EI | 0.034 |
| Respiratory | 0.043 |
| NR-Aromatase | 0.552 |
| Antiviral | Yes |
| Prediction | 0.70268 |